Pharmacovigilance (PV) in seasonal malaria chemoprevention (SMC) involves the identification and reporting of suspected adverse drugs reactions (ADR). Although PV is a core component of SMC, its functionality has not been well evaluated in Nigeria, where about four million eligible children received SMC in 2019. SMC implementation includes a referral and reporting system, used by health facility workers to inform the National Pharmacovigilance Centre, via National Agency for Food and Drug Administration and Control state offices, of SMC-related ADR among communities.
This poster was presented at the 69th annual meeting of the American Society of Tropical Medicine and Hygiene.Capacity development | Community delivery | Research | Health system strengthening | Use of evidence | Malaria | Seasonal malaria chemoprevention | SDG3
« Back to Publications